Covered recipient · General Payments record
PAMELA CAROLE THOMAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$328.89
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.89 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $193.68 | 4 |
| Lilly USA, LLC | $48.46 | 3 |
| Indivior Inc. | $34.91 | 1 |
| EISAI INC. | $30.90 | 1 |
| Novo Nordisk AS | $20.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $328.89 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $41.98 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104645605 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.16 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105872809 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.83 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104459570 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.71 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105554294 | CMS |
| Eisai Inc. | $30.90 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110817696 | CMS |
| Indivior Inc. | $34.91 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144573487 | CMS |
| Lilly USA, LLC | $18.81 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135877019 | CMS |
| Lilly USA, LLC | $15.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135853263 | CMS |
| Lilly USA, LLC | $14.35 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940340 | CMS |
| Novo Nordisk Inc | $20.94 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100568248 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.